MANNING & NAPIER ADVISORS LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 62039
Fairport, NY
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$167,955
-$595,391 QoQ
Shares Held
335
-78.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,313
of 2,602 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $976,966 across 8 Diagnostics & Research names. TMO ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
3,663 | $776,372 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
335 | $167,955 | |
| 3 | NTRA |
Natera, Inc.
|
58 | $15,744 | |
| 4 | ILMN |
Illumina, Inc.
|
38 | $6,681 | |
| 5 | DHR |
Danaher Corp /De/
|
24 | $4,571 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
14 | $3,175 | |
| 7 | GH |
Guardant Health, Inc.
|
16 | $2,400 | |
| 8 | GRAL |
GRAIL, Inc.
|
1 | $68 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,955 | 335 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $763,346 | 1,553 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,699,208 | 6,384 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $141,090,377 | 290,896 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $126,646,647 | 312,353 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $180,684,033 | 363,111 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $139,214,588 | 267,602 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $120,019,281 | 194,027 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $78,265,537 | 141,529 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||